Sun Pharma reports 26% fall in Q3 consolidated net profit

06 Feb 2020 Evaluate

Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2019.

The company has reported net profit of Rs 468.76 crore for the quarter under review as compared to net loss of Rs 38.68 crore for the same quarter in the previous year. Total income of the company increased by 32.32% at Rs 3,028.91 crore for Q3FY20 as compared Rs 2,289.02 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 26.44% in its net profit after taxes, share of profit of associates and joint ventures and non-controlling interests at Rs 913.52 crore for the quarter under review as compared to Rs 1,241.85 crore for the same quarter in the previous year. However, total income of the company increased by 4.30% at Rs 8,274.73 crore for Q3FY20 as compared Rs 7,933.25 crore for the corresponding quarter previous year.

Sun Pharma Inds. Share Price

1786.05 -40.05 (-2.19%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.